DTC on the Hill
Senate Appropriations/Agriculture subcommittee chair Herb Kohl (D-Wisc.) will meet with FDA Commissioner Andrew von Eschenbach Jan. 10 to discuss gaps in regulatory oversight of direct to consumer advertising that were highlighted by a Dec. 14 Government Accountability Office report (1"The Pink Sheet" Dec. 18, 2006, p. 20). The report, commissioned by Kohl, found the agency lacks documented criteria for identifying and prioritizing DTC material for review. Shortly after its release, Kohl sent a letter to President George Bush calling for reform of FDA's DTC review policy and an enhanced budget to accommodate the agency's increasing review burden...
You may also be interested in...
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.